A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
Clinical trial NCT03368859 · TERMINATED
Trial details
- NCT number
- NCT03368859
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2019-12-18
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.